Alimera Sciences (ALIM) Stock Forecast, Price Target & Predictions
ALIM Stock Forecast
Alimera Sciences stock forecast is as follows: an average price target of $5.75 (represents a 3.79% upside from ALIM’s last price of $5.54) and a rating consensus of 'Hold', based on 9 wall street analysts offering a 1-year stock forecast.
ALIM Price Target
ALIM Analyst Ratings
Hold
Alimera Sciences Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jun 25, 2024 | Yi Chen | H.C. Wainwright | $6.00 | $5.54 | 8.30% | 8.30% |
Jun 24, 2024 | Chase Knickerbocker | Craig-Hallum | $5.50 | $5.54 | -0.72% | -0.72% |
Jul 28, 2022 | - | H.C. Wainwright | $9.00 | $5.49 | 63.93% | 62.45% |
May 10, 2022 | - | H.C. Wainwright | $8.00 | $5.05 | 58.42% | 44.40% |
10
Alimera Sciences Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 2 |
Avg Price Target | - | - | $5.75 |
Last Closing Price | $5.54 | $5.54 | $5.54 |
Upside/Downside | -100.00% | -100.00% | 3.79% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jun 25, 2024 | Alliance Global Partners | Buy | Neutral | Downgrade |
Jun 25, 2024 | H.C. Wainwright | - | Neutral | Downgrade |
Jun 24, 2024 | Craig-Hallum | - | Hold | Downgrade |
Jun 12, 2023 | Raymond James | - | Strong Buy | Upgrade |
Jun 12, 2023 | Credit Suisse | - | Neutral | Downgrade |
Jun 12, 2023 | Morgan Stanley | - | Underweight | Downgrade |
Jun 12, 2023 | BMO Capital | - | Market Perform | Downgrade |
Jun 12, 2023 | Scotiabank | - | Outperform | Upgrade |
Jun 12, 2023 | William Blair | - | Outperform | Upgrade |
Jun 12, 2023 | Alliance Global Partners | - | Buy | Upgrade |
10
Alimera Sciences Financial Forecast
Alimera Sciences Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $26.31M | $23.36M | $17.54M | $13.55M | $14.03M | $13.60M | $14.60M | $11.90M | $13.96M | $12.15M | $21.70M | $11.21M | $13.77M | $12.47M | $10.04M | $14.54M | $17.35M | $12.85M |
Avg Forecast | $35.90M | $31.80M | $32.20M | $27.90M | $33.03M | $29.97M | $29.57M | $25.93M | $29.90M | $27.43M | $25.74M | $22.25M | $24.33M | $22.70M | $20.47M | $12.30M | $14.63M | $15.05M | $13.14M | $12.53M | $13.40M | $12.37M | $16.04M | $11.40M | $13.43M | $10.89M | $6.58M | $14.09M | $14.99M | $12.79M |
High Forecast | $35.90M | $31.80M | $32.20M | $27.90M | $33.03M | $29.97M | $29.57M | $25.93M | $29.90M | $27.43M | $25.74M | $22.25M | $24.33M | $22.70M | $20.47M | $12.30M | $14.63M | $15.05M | $13.14M | $12.53M | $13.40M | $12.37M | $16.04M | $11.40M | $13.43M | $10.89M | $6.58M | $14.09M | $14.99M | $12.79M |
Low Forecast | $35.90M | $31.80M | $32.20M | $27.90M | $33.03M | $29.97M | $29.57M | $25.93M | $29.90M | $27.43M | $25.74M | $22.25M | $24.33M | $22.70M | $20.47M | $12.30M | $14.63M | $15.05M | $13.14M | $12.53M | $13.40M | $12.37M | $16.04M | $11.40M | $13.43M | $10.89M | $6.58M | $14.09M | $14.99M | $12.79M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.03% | 0.86% | 1.10% | 0.96% | 0.90% | 1.11% | 0.95% | 1.04% | 0.98% | 1.35% | 0.98% | 1.03% | 1.15% | 1.52% | 1.03% | 1.16% | 1.00% |
Forecast
Alimera Sciences EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $3.76M | $-6.24M | $-14.17M | $-2.62M | $-1.43M | $-2.75M | $-1.30M | $-3.46M | $-2.12M | $-2.34M | $10.19M | $-1.67M | $1.01M | $1.35M | $-505.00K | $791.00K | $2.15M | $-1.16M |
Avg Forecast | $-292.06K | $-258.70K | $-261.96K | $-226.98K | $-268.74K | $-243.79K | $-240.53K | $-210.98K | $-243.24K | $-223.16K | $-209.41K | $-4.80M | $-197.96K | $-184.67K | $-166.50K | $-3.79M | $-1.52M | $-122.41K | $-106.87K | $-3.00M | $-109.05K | $-100.64K | $-130.49K | $-1.39M | $-109.29K | $-88.61K | $-53.56K | $1.03M | $-121.98K | $-104.03K |
High Forecast | $-292.06K | $-258.70K | $-261.96K | $-226.98K | $-268.74K | $-243.79K | $-240.53K | $-210.98K | $-243.24K | $-223.16K | $-209.41K | $-3.84M | $-197.96K | $-184.67K | $-166.50K | $-3.03M | $-1.22M | $-122.41K | $-106.87K | $-2.40M | $-109.05K | $-100.64K | $-130.49K | $-1.11M | $-109.29K | $-88.61K | $-53.56K | $1.23M | $-121.98K | $-104.03K |
Low Forecast | $-292.06K | $-258.70K | $-261.96K | $-226.98K | $-268.74K | $-243.79K | $-240.53K | $-210.98K | $-243.24K | $-223.16K | $-209.41K | $-5.76M | $-197.96K | $-184.67K | $-166.50K | $-4.55M | $-1.83M | $-122.41K | $-106.87K | $-3.60M | $-109.05K | $-100.64K | $-130.49K | $-1.67M | $-109.29K | $-88.61K | $-53.56K | $821.17K | $-121.98K | $-104.03K |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -19.01% | 33.76% | 85.12% | 0.69% | 0.93% | 22.44% | 12.20% | 1.15% | 19.41% | 23.28% | -78.05% | 1.20% | -9.26% | -15.25% | 9.43% | 0.77% | -17.58% | 11.18% |
Forecast
Alimera Sciences Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-3.78M | $-1.35M | $-10.03M | $-8.30M | $-3.78M | $-5.26M | $-3.12M | $-7.76M | $-4.11M | $-4.18M | $7.57M | $-3.65M | $-977.00K | $-618.00K | $-2.55M | $-1.20M | $498.00K | $-3.14M |
Avg Forecast | $6.53M | $3.26M | $3.26M | $-543.84K | $5.98M | $1.90M | $1.63M | $-1.36M | $1.99M | $-543.84K | $-1.99M | $-7.32M | $1.09M | $6.53M | $271.92K | $-5.79M | $-2.96M | $-21.75M | $-36.44M | $-4.57M | $-22.84M | $-28.55M | $57.65M | $-3.04M | $-2.36M | $-18.22M | $-67.98M | $-1.55M | $-16.10M | $-29.91M |
High Forecast | $6.53M | $3.26M | $3.26M | $-543.84K | $5.98M | $1.90M | $1.63M | $-1.36M | $1.99M | $-543.84K | $-1.99M | $-5.86M | $1.09M | $6.53M | $271.92K | $-4.63M | $-2.37M | $-21.75M | $-36.44M | $-3.66M | $-22.84M | $-28.55M | $58.97M | $-2.43M | $-2.36M | $-18.22M | $-67.98M | $-1.24M | $-16.10M | $-29.91M |
Low Forecast | $6.53M | $3.26M | $3.26M | $-543.84K | $5.98M | $1.90M | $1.63M | $-1.36M | $1.99M | $-543.84K | $-1.99M | $-8.78M | $1.09M | $6.53M | $271.92K | $-6.94M | $-3.55M | $-21.75M | $-36.44M | $-5.49M | $-22.84M | $-28.55M | $56.32M | $-3.65M | $-2.36M | $-18.22M | $-67.98M | $-1.87M | $-16.10M | $-29.91M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -3.48% | -0.21% | -36.88% | 1.43% | 1.28% | 0.24% | 0.09% | 1.70% | 0.18% | 0.15% | 0.13% | 1.20% | 0.41% | 0.03% | 0.04% | 0.77% | -0.03% | 0.10% |
Forecast
Alimera Sciences SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $14.15M | $11.55M | $10.81M | $9.97M | $9.10M | $9.86M | $9.81M | $10.09M | $10.37M | $8.56M | $8.69M | $8.23M | $8.44M | $7.38M | $7.36M | $8.85M | $10.31M | $9.56M |
Avg Forecast | $23.32M | $20.65M | $20.91M | $18.12M | $21.46M | $19.46M | $19.20M | $16.84M | $19.42M | $17.82M | $16.72M | $12.41M | $15.80M | $14.74M | $13.29M | $9.81M | $7.47M | $9.77M | $8.53M | $7.75M | $8.71M | $8.03M | $10.42M | $6.86M | $8.73M | $7.07M | $4.28M | $11.49M | $9.74M | $8.31M |
High Forecast | $23.32M | $20.65M | $20.91M | $18.12M | $21.46M | $19.46M | $19.20M | $16.84M | $19.42M | $17.82M | $16.72M | $14.89M | $15.80M | $14.74M | $13.29M | $11.77M | $8.96M | $9.77M | $8.53M | $9.30M | $8.71M | $8.03M | $10.42M | $8.23M | $8.73M | $7.07M | $4.28M | $13.79M | $9.74M | $8.31M |
Low Forecast | $23.32M | $20.65M | $20.91M | $18.12M | $21.46M | $19.46M | $19.20M | $16.84M | $19.42M | $17.82M | $16.72M | $9.92M | $15.80M | $14.74M | $13.29M | $7.85M | $5.97M | $9.77M | $8.53M | $6.20M | $8.71M | $8.03M | $10.42M | $5.49M | $8.73M | $7.07M | $4.28M | $9.19M | $9.74M | $8.31M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 0.78% | 0.81% | 1.02% | 1.22% | 1.01% | 1.15% | 1.30% | 1.19% | 1.07% | 0.83% | 1.20% | 0.97% | 1.04% | 1.72% | 0.77% | 1.06% | 1.15% |
Forecast
Alimera Sciences EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.07 | $-0.04 | $-1.24 | $-1.18 | $-0.54 | $-0.75 | $-0.45 | $-1.11 | $-0.59 | $-0.60 | $1.03 | $-0.63 | $-0.18 | $-0.12 | $-0.51 | $-0.24 | $0.08 | $-0.60 |
Avg Forecast | $0.12 | $0.06 | $0.06 | $-0.01 | $0.11 | $0.04 | $0.03 | $-0.03 | $0.04 | $-0.01 | $-0.04 | $-0.06 | $0.02 | $0.12 | $0.01 | $-0.52 | $-0.34 | $-0.40 | $-0.67 | $-0.74 | $-0.42 | $-0.53 | $1.06 | $-0.54 | $-0.04 | $-0.34 | $-1.25 | $-0.40 | $-0.30 | $-0.55 |
High Forecast | $0.12 | $0.06 | $0.06 | $-0.01 | $0.11 | $0.04 | $0.03 | $-0.03 | $0.04 | $-0.01 | $-0.04 | $-0.06 | $0.02 | $0.12 | $0.01 | $-0.52 | $-0.34 | $-0.40 | $-0.67 | $-0.74 | $-0.42 | $-0.53 | $1.08 | $-0.54 | $-0.04 | $-0.34 | $-1.25 | $-0.40 | $-0.30 | $-0.55 |
Low Forecast | $0.12 | $0.06 | $0.06 | $-0.01 | $0.11 | $0.04 | $0.03 | $-0.03 | $0.04 | $-0.01 | $-0.04 | $-0.06 | $0.02 | $0.12 | $0.01 | $-0.52 | $-0.34 | $-0.40 | $-0.67 | $-0.74 | $-0.42 | $-0.53 | $1.04 | $-0.54 | $-0.04 | $-0.34 | $-1.25 | $-0.40 | $-0.30 | $-0.55 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -3.48% | -0.35% | -248.00% | 2.29% | 1.61% | 1.88% | 0.67% | 1.49% | 1.40% | 1.14% | 0.97% | 1.17% | 4.15% | 0.36% | 0.41% | 0.61% | -0.27% | 1.09% |
Forecast